• Publications
  • Influence
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global
TLDR
All-cause age-standardised YLD rates decreased by 3·9% from 1990 to 2017; however, the all-age YLD rate increased by 7·2% while the total sum of global YLDs increased from 562 million (421–723) to 853 million (642–1100).
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
TLDR
The Global Burden of Disease 2016 Study provides a comprehensive assessment of cause-specific mortality for 264 causes in 195 locations from 1980 to 2016, and evaluation of the expected epidemiological transition with changes in development and where local patterns deviate from these trends is evaluated.
Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
TLDR
The results presented here are the estimates of burden due to overall stroke and ischaemic and haemorrhagic stroke from GBD 2016, indicating that the burden of stroke is likely to remain high.
Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
TLDR
It is found that the risk of all-cause mortality, and of cancers specifically, rises with increasing levels of consumption, and the level of consumption that minimises health loss is zero.
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
TLDR
The burden of neurological disorders, as measured by the absolute number of DALYs, continues to increase and the scarcity of established modifiable risks for most of the neurological burden demonstrates that new knowledge is required to develop effective prevention and treatment strategies.
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  • Theo Stephen S Cristiana Kaja M Mohammad Mitra Mohsen H Vos Lim Abbafati Abbas Abbasi Abbasifard Abbasi-Ka, T. Vos, +1,028 authors C. Murray
  • Medicine
    The Lancet
  • 17 October 2020
TLDR
Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates, and there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries.
Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model.
TLDR
FTAP is an effective and cost-saving measure for mitigating pandemic influenza and in combination with school closure as well as prevaccination is the most effective single strategy.
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic
TLDR
The patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure of disability-adjusted life-years (DALYs), a composite measure of disease burden capturing both premature mortality and prevalence and severity of ill health, over the past 28 years are assessed.
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  • Christopher J L Aleksandr Y Peng Cristiana Kaja M Mohsen Foad Murray Aravkin Zheng Abbafati Abbas Abbasi-Kangeva, C. Murray, +938 authors Stephen S. Lim
  • Medicine
    The Lancet
  • 17 October 2020
TLDR
The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and economic development, including household air pollution; unsafe water, sanitation, and handwashing; and child growth failure.
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  • E. Ray Alexis Emma Foad Ahmed Jose C. Mustafa Geleto Dorsey Elbaz Nichols Abd-Allah Abdelalim Adsuar An, E. Dorsey, +64 authors C. Murray
  • Medicine
    The Lancet Neurology
  • 1 November 2018
TLDR
Over the past generation, the global burden of Parkinson's disease has more than doubled as a result of increasing numbers of older people, with potential contributions from longer disease duration and environmental factors.
...
1
2
3
4
5
...